<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001025</url>
  </required_header>
  <id_info>
    <org_study_id>Absorb/Xience 01</org_study_id>
    <nct_id>NCT02001025</nct_id>
  </id_info>
  <brief_title>Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rudolf Berger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biodegradable ABSORB scaffold is characterized by a greater strut thickness, but it has a
      greater flexibility compared to the XIENCE stent. Due to its fragility the inflating pressure
      of the ABSORB scaffold is limited and suitable lesions have to be well prepared. This study
      assesses the incidence of malapposed stent-struts, and the frequency of stent-underexpansion
      and edge dissection after ABSORB implantation compared to the XIENCE stent.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>adverse post-stenting results</measure>
    <time_frame>1 year</time_frame>
    <description>Malapposition, underexpansion and edge dissections assessed with Optical Coherence Tomography (OCT)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bioresorbable Scaffolds</condition>
  <arm_group>
    <arm_group_label>Absorb scaffold</arm_group_label>
    <description>Bioresorbable vascular scaffold implanted in coronary arteries, which are completely resorbed over a period of approximately two years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xience stent</arm_group_label>
    <description>Second generation drug-eluting stent to treat coronary artery lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Absorb scaffold</intervention_name>
    <arm_group_label>Absorb scaffold</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xience stent</intervention_name>
    <arm_group_label>Xience stent</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for implanting an Absorb scaffold:

          -  age &lt; 55 years OR

          -  lesion length &gt; 24mm OR

          -  multiple lesions to be treated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniel Dalos, MD</last_name>
    <phone>+43 1 40400 4614</phone>
    <email>daniel.dalos@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rudolf Berger, PD MD</last_name>
    <phone>+43 1 40400 4614</phone>
    <email>rudolf.berger@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Berger, PD MD</last_name>
      <phone>+43 1 40400 4614</phone>
      <email>rudolf.berger@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Rudolf Berger, PD MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Dalos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clemens Gangl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Roth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Neunteufl, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georg Delle-Karth, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irene Lang, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2013</study_first_submitted>
  <study_first_submitted_qc>November 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2013</study_first_posted>
  <last_update_submitted>November 27, 2013</last_update_submitted>
  <last_update_submitted_qc>November 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Rudolf Berger</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>coronary vessels</keyword>
  <keyword>coronary stenosis</keyword>
  <keyword>percutaneous transluminal angioplasty</keyword>
  <keyword>stents</keyword>
  <keyword>drug-eluting stents</keyword>
  <keyword>bioresorbable scaffolds</keyword>
  <keyword>optical coherence tomography</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

